Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Pain, Postoperative 5Pain 2Chronic Pain 2Breast Neoplasms 2Spinal Cord Neoplasms 1Seizures 1Pinealoma 1Oropharyngeal Neoplasms 1Oligodendroglioma 1Neuroectodermal Tumors, Primitive 1Neuralgia 1Neoplasms 1Meningioma 1Medulloblastoma 1Lymphoma, Follicular 1Liver Neoplasms 1Hot Flashes 1Gliosarcoma 1Glioma 1Glioblastoma 1Ependymoma 1Central Nervous System Neoplasms 1Carcinoma, Hepatocellular 1Breast Cancer Patient 1Brain Neoplasms 1Astrocytoma 1Acute Pain 1

Interventions

Gemcitabine 109Paclitaxel 92Carboplatin 79Bevacizumab 75pembrolizumab 74Surveys and Questionnaires 70Docetaxel 69Cisplatin 67Nivolumab 48Exercise 48Capecitabine 48Cyclophosphamide 47Sorafenib 43Fluorouracil 43Irinotecan 42Pemetrexed 37Albumin-Bound Paclitaxel 35Radiotherapy 34Dexamethasone 34Blood Specimen Collection 34Oxaliplatin 31Leucovorin 31Erlotinib Hydrochloride 31trametinib 30130-nm albumin-bound paclitaxel 29Cetuximab 28Therapeutics 26Ipilimumab 26Standard of Care 25Methods 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Neoplasms × Pregabalin × Clear all
NCT00637975 2011-02-02

Oxycodone and Pregabalin for the Treatment of Oncological Neuropathic Pain

Associazione Progetto Oncologia UMAN.A

Phase 2 Completed
80 enrolled

Neoplasms, Neuralgia, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡